- Activity pressure is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
MDTN
MEX
Week ended 31 Jul 2026
Weekly Investor Report
Medtronic plc · Healthcare · Medical Devices
Latest close
1,496 MXN
4.6%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -2.0% below the Trend Line and sits at 32.8% of its 52-week range. The latest completed week returned 4.6%, after a 3.9% four-week move. The latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal.
Setup score
39
out of 100
Latest Close
1,496 MXN
31 Jul 2026
1W Return
4.6%
latest completed week
4W Return
3.9%
short-term follow-through
12W Return
8.1%
quarterly tape
Trend Breadth
34.6%
18 of 52 weeks active
Volume Ratio
0.4x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 27.15% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
4.6%
Latest completed week; four-week move 3.9%.
Indicator stack
19/83
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 27.15%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
55/100
20 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -2.0% below the Trend Line and sits at 32.8% of its 52-week range. The latest completed week returned 4.6%, after a 3.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0612-week average 0.07
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.06Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 3.9% over four weeks, 8.1% over 12 weeks, and -10.2% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year18
Trend breadth34.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.65Latest activity-pressure read.
Pressure change263.5%Four-week change in activity pressure.
Leadership-10.06Latest relative-leadership reading.
RS change35.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment55/100
Weighted news tone is neutral across 20 relevant articles.
11 positive · 6 neutral · 3 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-19.3%Distance below the 52-week high.
13-week volatility3.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher10 of 2610 weeks finished lower.
Best week+5.7%Week of 5 Jun.
Worst week-7.1%Week of 20 Feb.
Latest week+4.6%Week of 31 Jul.
Shape of recent returns
Strong gains3
Modest gains7
Flat weeks6
Modest losses5
Sharp losses5
Recent vol3.1%13-week weekly-return volatility.
Base vol2.6%52-week weekly-return volatility.
Up/down split16/14Count of positive and negative weeks in the 52-week window.
Average skew2.3% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorMX Healthcare
4-week rank20 / 78
Group average-1.3%
Trend breadth28.2%
Trend28.2%active weekly trend signals
MD62.8%positive activity pressure
RS35.9%positive relative leadership
Four-week leaders
IndustryMX Medical Devices
4-week rank5 / 9
Group average4.4%
Trend breadth11.1%
Trend11.1%active weekly trend signals
MD55.6%positive activity pressure
RS11.1%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape35/100
Trend, activity pressure, participation, and risk combine to a 35/100 tape read.
Indicator analysis15/100Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 0/12.
Activity pressure 0.06; No reversal markers Next-Week ExpectancyNegative 27.15%Next-week expectancy is negative with a 27.15% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment55/100Weighted news tone is neutral across 20 relevant articles.
Needham reiterates Medtronic stock rating on renal device growth Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 1,496 MXN | 4.6% | 1,527 MXN | 1,578 MXN | 0.65 | -10.06 | 454 | Off |
| 24 Jul 2026 | 1,430 MXN | -2.7% | 1,536 MXN | 1,578 MXN | 0.54 | -13.79 | 5 | Off |
| 17 Jul 2026 | 1,470 MXN | 1.2% | 1,548 MXN | 1,578 MXN | 0.40 | -12.22 | 314 | Off |
| 10 Jul 2026 | 1,453 MXN | 0.9% | 1,558 MXN | 1,578 MXN | -0.01 | -13.58 | 1.6K | Off |
| 3 Jul 2026 | 1,440 MXN | 2.1% | 1,572 MXN | 1,578 MXN | -0.40 | -15.56 | 100 | Off |
| 26 Jun 2026 | 1,410 MXN | 5.4% | 1,585 MXN | 1,579 MXN | -0.73 | -17.98 | 0 | Off |
| 19 Jun 2026 | 1,338 MXN | -2.9% | 1,596 MXN | 1,579 MXN | -1.08 | -23.19 | 0 | Off |
| 12 Jun 2026 | 1,378 MXN | -1.6% | 1,609 MXN | 1,580 MXN | -1.21 | -21.78 | 0 | Off |
| 5 Jun 2026 | 1,399 MXN | 5.7% | 1,621 MXN | 1,581 MXN | -1.32 | -18.89 | 0 | Off |
| 29 May 2026 | 1,324 MXN | 0.2% | 1,632 MXN | 1,582 MXN | -1.45 | -26.40 | 54 | Off |
| 22 May 2026 | 1,322 MXN | 0.0% | 1,645 MXN | 1,584 MXN | -1.44 | -26.75 | 0 | Off |
| 15 May 2026 | 1,322 MXN | -4.5% | 1,659 MXN | 1,585 MXN | -1.43 | -26.85 | 12.6K | Off |
| 8 May 2026 | 1,384 MXN | 0.0% | 1,674 MXN | 1,587 MXN | -1.48 | -25.98 | 0 | Off |
| 1 May 2026 | 1,384 MXN | -5.5% | 1,688 MXN | 1,588 MXN | -1.50 | -24.33 | 3.2K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.